KRAS Altered Advanced or Metastatic Solid Tumors
Oncology·MeSH: Carcinoma, Non-Small-Cell Lung
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| amg 410 | AMGEN INC (AMGN) |
Frequently asked questions
How many drugs are in development for KRAS Altered Advanced or Metastatic Solid Tumors?
BioSniper tracks 1 drug in development for KRAS Altered Advanced or Metastatic Solid Tumors across 1 company.
How many clinical trials target KRAS Altered Advanced or Metastatic Solid Tumors?
There are 1 clinical trial targeting KRAS Altered Advanced or Metastatic Solid Tumors tracked by BioSniper.
Deep-dive into KRAS Altered Advanced or Metastatic Solid Tumors
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis